A randomized, double-blind comparison of atomoxetine hydrochloride and placebo in child and adolescent outpatients with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder [ODD]
Phase of Trial: Phase III
Latest Information Update: 29 Sep 2008
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder; Behavioural disorders
- Focus Therapeutic Use
- 29 Sep 2008 Last checked against ClinicalTrials.gov record on 29 Sep 2008.
- 01 Feb 2008 Results have been published (1096613)
- 27 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.